{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:32:07Z","timestamp":1793251927543,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":258,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.toxrep.2022.09.007","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T11:44:23Z","timestamp":1663415063000},"page":"1796-1805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A survey on the incidence of common musculoskeletal side effects among the patients taking long-term anti-ulcerant therapies in Bangladesh"],"prefix":"10.1016","volume":"9","author":[{"given":"Shuvo","family":"Mitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Saddam","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubiya","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Abdus","family":"Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanoy","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarmin","family":"Farzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.toxrep.2022.09.007_bib1","doi-asserted-by":"crossref","first-page":"13858","DOI":"10.18632\/oncotarget.4030","article-title":"Understanding the gastrointestinal tract of the elderly to develop dietary solutions that prevent malnutrition","volume":"6","author":"R\u00e9mond","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.toxrep.2022.09.007_bib2","unstructured":"Aurif, F., A prospectiv study of comparision between efficacy of topical sucralfate and conventional dressings in the management of chronic lower limb ulcers, 2011."},{"issue":"9","key":"10.1016\/j.toxrep.2022.09.007_bib3","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1572-0241.2006.00723.x","article-title":"The burden of gastrointestinal and liver diseases, 2006","volume":"101","author":"Shaheen","year":"2006","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.toxrep.2022.09.007_bib4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/pds.1969","article-title":"Marked increase in proton pump inhibitors use in Australia","volume":"19","author":"Hollingworth","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.toxrep.2022.09.007_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25 years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.toxrep.2022.09.007_bib6","series-title":"Are H2 Receptor Antagonists Safe over the Counter Drugs?","author":"Andersen","year":"1994"},{"key":"10.1016\/j.toxrep.2022.09.007_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2036.1993.tb00597.x","article-title":"Safety issues relating to long\u2010term treatment with histamine H2\u2013receptor antagonists","volume":"7","author":"Sabesin","year":"1993","journal-title":"Aliment. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.toxrep.2022.09.007_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.reprotox.2004.09.002","article-title":"Pregnancy outcome after exposure to ranitidine and other H2-blockers: a collaborative study of the European Network of Teratology Information Services","volume":"19","author":"Garbis","year":"2005","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.toxrep.2022.09.007_bib9","first-page":"c20","article-title":"Temperature-dependent formation of N-nitrosodimethylamine during the storage of ranitidine reagent powders and tablets","author":"Abe","year":"2020","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.toxrep.2022.09.007_bib10","series-title":"FDA Recalls Ranitidine Medicines over Potential Cancer Causing Impurity","author":"Mahase","year":"2019"},{"issue":"9","key":"10.1016\/j.toxrep.2022.09.007_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/pds.4043","article-title":"Proton pump inhibitor prescribing patterns in the UK: a primary care database study","volume":"25","author":"Othman","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"5","key":"10.1016\/j.toxrep.2022.09.007_bib12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.toxrep.2022.09.007_bib13","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","article-title":"Systematic review of the risk of enteric infection in patients taking acid suppression","volume":"102","author":"Leonard","year":"2007","journal-title":"Am. J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.toxrep.2022.09.007_bib14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/apt.13583","article-title":"High risk of drug\u2010induced microscopic colitis with concomitant use of NSAID s and proton pump inhibitors","volume":"43","author":"Verhaegh","year":"2016","journal-title":"Aliment. Pharm. Ther."},{"issue":"5","key":"10.1016\/j.toxrep.2022.09.007_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","article-title":"Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis","volume":"11","author":"Lo","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.toxrep.2022.09.007_bib16","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.cgh.2016.05.018","article-title":"Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis","volume":"14","author":"Tran-Duy","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"22","key":"10.1016\/j.toxrep.2022.09.007_bib17","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.2013.280490","article-title":"Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency","volume":"310","author":"Lam","year":"2013","journal-title":"Jama"},{"issue":"11","key":"10.1016\/j.toxrep.2022.09.007_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112558","article-title":"The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis","volume":"9","author":"Park","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.toxrep.2022.09.007_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00198-018-4788-y","article-title":"Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies","volume":"30","author":"Poly","year":"2019","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.toxrep.2022.09.007_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.lfs.2018.12.058","article-title":"Proton pump inhibitors therapy and risk of bone diseases: an update meta-analysis","volume":"218","author":"Liu","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.toxrep.2022.09.007_bib21","first-page":"5","article-title":"Micronutrient deficiencies among children and women in Bangladesh: progress and challenges","author":"Ahmed","year":"2016","journal-title":"J. Nutr. Sci."},{"issue":"1","key":"10.1016\/j.toxrep.2022.09.007_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-016-0805-4","volume":"35","author":"Okazaki","year":"2017","journal-title":"J. Bone Miner. Metab."},{"issue":"12","key":"10.1016\/j.toxrep.2022.09.007_bib23","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1515\/CCLM.2007.362","article-title":"The role of hyperhomocysteinemia as well as folate, vitamin B6 and B12 deficiencies in osteoporosis\u2013a systematic review","volume":"45","author":"Herrmann","year":"2007","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"2","key":"10.1016\/j.toxrep.2022.09.007_bib24","first-page":"255","article-title":"The use of blood analysis to evaluate trace mineral status in ruminant livestock","volume":"27","author":"Herdt","year":"2011","journal-title":"Vet. Clin.: Food Anim. Pract."},{"key":"10.1016\/j.toxrep.2022.09.007_bib25","first-page":"S2","article-title":"The effect of proton pump-inhibiting drugs on mineral metabolism","volume":"104","author":"Insogna","year":"2009","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.toxrep.2022.09.007_bib26","first-page":"9","article-title":"Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures","volume":"64","author":"Fournier","year":"2009","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.toxrep.2022.09.007_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3177\/jnsv.44.473","article-title":"Effect of l-lactic acid on calcium absorption in rats fed omeprazole","volume":"44","author":"Chonan","year":"1998","journal-title":"J. Nutr. Sci. Vitaminol."},{"issue":"1","key":"10.1016\/j.toxrep.2022.09.007_bib28","first-page":"339","article-title":"Proton-pump inhibitors and risk of fractures: an update meta-analysis","volume":"27","author":"Zhou","year":"2016","journal-title":"J. Bone Metab."},{"issue":"2","key":"10.1016\/j.toxrep.2022.09.007_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/00365520903434117","article-title":"Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis","volume":"45","author":"Sipponen","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"issue":"17","key":"10.1016\/j.toxrep.2022.09.007_bib30","first-page":"1834","article-title":"Proton-pump inhibitors and hypomagnesemic hypoparathyroidism","volume":"355","author":"Epstein","year":"2006","journal-title":"Indian J. Pharm."},{"issue":"2","key":"10.1016\/j.toxrep.2022.09.007_bib31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2265.2008.03194.x","article-title":"Severe hypomagnesaemia in long\u2010term users of proton\u2010pump inhibitors","volume":"69","author":"Cundy","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.toxrep.2022.09.007_bib32","doi-asserted-by":"crossref","first-page":"a425","DOI":"10.1136\/bmj.39505.738981.BE","article-title":"Omeprazole and refractory hypomagnesaemia","volume":"337","author":"Shabajee","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.toxrep.2022.09.007_bib33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/qjmed\/hcq021","article-title":"Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series","volume":"103","author":"Mackay","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.toxrep.2022.09.007_bib34","doi-asserted-by":"crossref","unstructured":"M.A. Broeren\u00a0et al., Hypomagnesemia induced by several proton-pump inhibitors, vol. 151(no. 10), 2009, pp. 755\u20136.","DOI":"10.7326\/0003-4819-151-10-200911170-00016"},{"issue":"1","key":"10.1016\/j.toxrep.2022.09.007_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2009.11.019","article-title":"A case series of proton pump inhibitor\u2013induced hypomagnesemia","volume":"56","author":"Hoorn","year":"2010","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.toxrep.2022.09.007_bib36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1503\/cmaj.080873","article-title":"Proton pump inhibitors: balancing the benefits and potential fracture risks","volume":"179","author":"Richards","year":"2008","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.toxrep.2022.09.007_bib37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00223-012-9601-x","article-title":"Pantoprazole, a proton pump inhibitor, delays fracture healing in mice","volume":"90","author":"Histing","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.toxrep.2022.09.007_bib38","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2147\/DDDT.S260565","article-title":"Effects of calcium and annatto tocotrienol supplementation on bone loss induced by pantoprazole in male rats","volume":"14","author":"Chin","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.toxrep.2022.09.007_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5056\/jnm.2013.19.1.25","article-title":"Pharmacokinetics and pharmacodynamics of the proton pump inhibitors","volume":"19","author":"Shin","year":"2013","journal-title":"J. Neurogastroenterol. Motil."},{"key":"10.1016\/j.toxrep.2022.09.007_bib40","first-page":"S5","article-title":"Effect of proton pump inhibitors on vitamins and iron","volume":"104","author":"McColl","year":"2009","journal-title":"Am. J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.toxrep.2022.09.007_bib41","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrgastro.2009.125","article-title":"Insights into the future of gastric acid suppression","volume":"6","author":"DeVault","year":"2009","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.toxrep.2022.09.007_bib42","first-page":"193","article-title":"Adverse effects of proton pump inhibitors","volume":"24","author":"Lodato","year":"2010","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.toxrep.2022.09.007_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138881","article-title":"Dietary inulin fibers prevent proton-pump inhibitor (PPI)-induced hypocalcemia in mice","volume":"10","author":"Hess","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.toxrep.2022.09.007_bib44","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/MOG.0b013e32833ea9d9","article-title":"Adverse effects of proton pump inhibitor drugs: clues and conclusions","volume":"26","author":"McCarthy","year":"2010","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"10","key":"10.1016\/j.toxrep.2022.09.007_bib45","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/jgs.13661","article-title":"Hyperparathyroidism associated with long\u2010term proton pump inhibitors independent of concurrent bisphosphonate therapy in elderly adults","volume":"63","author":"Hinson","year":"2015","journal-title":"J. Am. Geriatr. Soc."},{"issue":"15","key":"10.1016\/j.toxrep.2022.09.007_bib46","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2169\/internalmedicine.2608-18","article-title":"Proton-pump inhibitor-induced severe hypomagnesemia and hypocalcemia are clinically masked by thiazide diuretic","volume":"58","author":"Uehara","year":"2019","journal-title":"Intern. Med."},{"issue":"5","key":"10.1016\/j.toxrep.2022.09.007_bib47","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3122\/jabfm.2009.05.090026","article-title":"Secondary hyperparathyroidism: pathophysiology and treatment","volume":"22","author":"Saliba","year":"2009","journal-title":"J. Am. Board Fam. Med."},{"issue":"3","key":"10.1016\/j.toxrep.2022.09.007_bib48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jbmr.3011","article-title":"Control of bone anabolism in response to mechanical loading and PTH by distinct mechanisms downstream of the PTH receptor","volume":"32","author":"Delgado\u2010Calle","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.toxrep.2022.09.007_bib49","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/07315724.1994.10718444","article-title":"Vitamin B12 malabsorption and omeprazole therapy","volume":"13","author":"Dutta","year":"1994","journal-title":"J. Am. Coll. Nutr."},{"issue":"3","key":"10.1016\/j.toxrep.2022.09.007_bib50","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF01308137","article-title":"Malabsorption of protein-bound cobalamin but not unbound cobalamin during cimetidine administration","volume":"25","author":"Steinberg","year":"1980","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.toxrep.2022.09.007_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/01639360903574734","article-title":"Vitamin B12 deficiency is linked with long-term use of proton pump inhibitors in institutionalized older adults: could a cyanocobalamin nasal spray be beneficial?","volume":"29","author":"Rozgony","year":"2010","journal-title":"J. Nutr. Elder."},{"issue":"11","key":"10.1016\/j.toxrep.2022.09.007_bib52","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1365-2036.2008.03658.x","article-title":"Vitamin B12 deficiency in hypersecretors during long\u2010term acid suppression with proton pump inhibitors","volume":"27","author":"Hirschowitz","year":"2008","journal-title":"Aliment. Pharm. Ther."},{"issue":"9","key":"10.1016\/j.toxrep.2022.09.007_bib53","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1359\/jbmr.1997.12.9.1486","article-title":"Reduced bone mass in Dutch adolescents fed a macrobiotic diet in early life","volume":"12","author":"Parsons","year":"1997","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.toxrep.2022.09.007_bib54","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jbmr.5650070514","article-title":"Risk of fractures in patients with pernicious anemia","volume":"7","author":"Goerss","year":"1992","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.toxrep.2022.09.007_bib55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM198807143190202","article-title":"Cobalamin and osteoblast-specific proteins","volume":"319","author":"Carmel","year":"1988","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.toxrep.2022.09.007_bib56","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0026-0495(96)90171-7","article-title":"Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells","volume":"45","author":"Kim","year":"1996","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.toxrep.2022.09.007_bib57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s001980050099","article-title":"Family history and risk of osteoporotic fracture","volume":"8","author":"Fox","year":"1998","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.toxrep.2022.09.007_bib58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/oxfordjournals.epirev.a036281","article-title":"Epidemiology of osteoporosis and osteoporotic fractures","volume":"7","author":"Cummings","year":"1985","journal-title":"Epidemiol. Rev."},{"issue":"5","key":"10.1016\/j.toxrep.2022.09.007_bib59","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bone.2004.06.017","article-title":"A family history of fracture and fracture risk: a meta-analysis","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.toxrep.2022.09.007_bib60","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00198-011-1713-z","article-title":"Interpretation and use of FRAX in clinical practice","volume":"22","author":"Kanis","year":"2011","journal-title":"Osteoporos. Int."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750022001913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750022001913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:42:59Z","timestamp":1793248979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750022001913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":60,"alternative-id":["S2214750022001913"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2022.09.007","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A survey on the incidence of common musculoskeletal side effects among the patients taking long-term anti-ulcerant therapies in Bangladesh","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2022.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}